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Abstract: The effect of antiallergic agent, azelastine, was examined in immunogical
secretory process of mast cells. 1. Azelastine significantly inhibited '"Ca uptake by mast
cells stimulated by antigen, and the maximum inhibition was attained at a concentra-
tion of 50 11 11/me showing approximately 30.5 % inhibition. 2. Azelastine also inhibite
the release of histamine from mast cells by antigen. The maximal inhibitory rate was
38.1 %. The effect of azelastine on '"Ca uptake and histamine release was dose-dependent,
and compatible at employed cocentration of the agent. 3. Tachpylaxis to azelastine was
not found in this experimental system.
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Introduction
Immunological secretory process of mast
cens is a model of triggering events in imme-
diate allergic reactions. In recent years many
antiallergic agents have been developed for
the purpose of inhibiting immunological
release of chemical mediators from mast
cells. The first developed antiallergic agent,
disodium cromoglycate (DSCG) has been
shown to act as a membrane stabilizer!).
Earlier studies on DSCG demonstrated that
the agent inhibited phosphodiesterase activit-
y2). It is also shown that the agent inhibits
an increased Ca2+ influx into mast cells fol-
lowing stimulation with antigen3-5).
It has been reported that azelastine, an
antiallergic agent, inhibits allergic and non-
alleregic release of SRS - N) and histamine
release7-1!). In addition to these inhibitory
effects, azelastine inhibits the production of
leukotrienes B, and C,12). The effect of azelas-
tine on Ca2+ influx into mast cells by stimu-
lation with antigen has not investigated.
In the present study inhibitory effect of
azelastine on <SCa uptake and histamine rele-
ase was examined in mast cells stimulated by
antigen.
Materials and Methods
Azelastine (4-(p-chlorobenzyl)-2-(hexahydor-
1-methy1-1H-azepine-4-yl)-1-(2H)-phthalazino-
ne hydrochloride) was presented by Eisai
Pharmaceutical Co. (Fig. D.
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CI
Fig. 1. Chemical structure of azelastin
Sprague Dawley rats were sensitized with
an intramuscular injection of 0.5 mf saline
containing ovalbumin, 50mg/mf, and 8x108
killed organisms (Bordetella pertussis) per
milliliter, into each hind limb according to
the method described by Foreman, et aP3).
12-14 days after sensitization, the rats were
sacrified, and mast cells were separated from
abdominal cavity with 200 times gentle mas-
sage. The cells purified by the density gradi-
ent of BSA14). The purity of mast was more
than 90%.
<SCa uptake by mast cells induced by anti-
gen was perfomed by the method14) modified
from that described by Ranadive, et aI'5). 3
,u Ci 45 Ca in 0.1 mP distilled water and 10
,ug/mP ovalbumin in 0.7mf of Tyrode's solu-
tion was added into each test tube. The test
tube was kept in water bath at 37°C for 30
min. After the number of mast cells was
adjusted to 105 cells/0.1mP, the cell suspen-
sion was added into the test tube containing
45Ca and ovalbumin, and kept in water bath
at 37"C. The mixed solution was incubated at
37°C for 10 min. After the mast cells were
washed twice with 5mP of cold physiological
saline, the residual free radioactive <SCa was
removed through microfiber filter (What-
man, type GF/C, pore SIze 1.2,um). The
amount of <SCa in each cell suspension was
determined by using a scintillation counter.
All experiments for 45Ca uptake was carried
out in triplicate.
Histamine release from mast cells induced
by antigen was examined under the same
condition as the experiment for 45Ca uptake
except for the incubation with antigen for 15
min. The histamine content in the cells and
supernatant fluid was measured by an auto-
mated spectrofluorometric histamine analysis
system. The results were expressed as a
percentage of total histamine content. All
experiments for histamine release were per-
formed in duplicate.
Tachyphylaxis t8) to azelastine was examined
by the re-exposure following incubation with
azelastine.
R~sults
Azelastine inhibited 45Ca uptake by mast
cells induced by antigen. The inhibitory effect
of azelastine was dose-dependent, and the
maximum inhibition was attained at a con-
centration of 50,ug/lnP showing approximately
30.5% inhibition. The rate of azelas-tine on
histamine release was 13.2% at 0.05,ug/mP,
15.2% at 0.5 M/mP, 35.0% at 5 ,ug/mP and
38.1% at 50,ug/mP. The inhibitory effect on
45Ca uptake and histamine release was signifi-
cantly higher at 5.0,u g/mf and 50,u g/mf
than the inhibition at 0.5 ,ug/mf of azelastine
(significant difference between inhibitory
effects at 0.5,u g/ mP and at 5,u g/ mP : Ca
uptake ; p<O.OOl, histamine release;
p<O.OOl) (Fig. 2).
Azelastine and <SCa uptake 91
5050
40
c
0
...
....
.... 30
.Q
...
.c
c
...
..
20
10
o
0.05 0.5 5.0 50.0
c
o
...
....
...
.Q
...
-a
H
dP
40
30
20
10
o
Calcium ions are considered to be indispen-
sable for the process of the release of chemi-
cal mediators from mast cells. Calcium ions
that enter cells from the extracellular fluid
upon stimlation with antigen play an impor-
tant role in the release of chemical mediators
through major routs. Firstly, Calcium ions
cause phosphorylation of proteins and induce
release of chemical mediators with granules
extruded from the cells. Histamine and hepa-
rin (preformed mediators) contained in gran-
ules are released in this fashion. Secondly,
calcium ions enhance the activity of phos-
pholipase A, and promote synthesis of
arachidonic acid mainly from phosphatidy-
lcholine. Prostaglandins and leukotrienes
Discussion
Effect of re-exposure with azelastin
(~) following previous incubation
with the agent (D) on the inhibi-
tion of "Ca uptake and histamine
release in mast cells stimulated by
antigen
Concentration of agent lpg/mIl
Fig. 2. Inhibitory effect of azelastin on <SCa
uptake (c:=:J) and histamine release
( -) III mast cells stimulated by
antigen
Tachyphylaxis to azelastin was not ob-
served in immunological secretory process of
mast cells. The inhibition of azelastine was
35.1% for <SCa uptake and 40.2% for hista-
mine release by single incubation with the
agent. A similar inhibition was obtained at
50 f.J, g/mP of azelastine, and 30.5% inhibition
for <SCa uptake and 38.1% for histamine
release when mast cells were re-exposed fol-
lowing previous exposure with the agent (Fig.
3).
Fig. 3.
45Ca uptake Histamine release
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(newly genarated mediators) are synthesized
and released by this rout.
Our previous studies have shown that a
calcium channel antagonists, nifedipine and
nicardipine, inhibit <SCa uptake by antigen-
stimulated mast cells, and consequently re-
duce histamine release19,20). Similar inhibitory
effect was observed in an antiallergic drug,
DSCG, suggesting that the agent also pre-
vents the influx of Ca'+ into mast cells upon
stimulation with antigen, thus inhibiting the
release of chemical mediators. The inhibitory
effect of DSCG, however, decreases by pro-
longed preincubation'1-23) or re-exposure with
the agent (tachyphylaxis)24).
Azelastine possesses potent histamine HI
receptor blocking properties7). It has been
reported that azelastine strikingly inhibits
the production of leukotrienes B, and C,l2).
Thus, azelastine inhibits allergic and non-
allergic release of SRS-A"·8) and histamine8-H).
In the present study, the effect of an
antiallergic agent, azelastine, was ezamined
in immunological secretory process of mast
cells. The results from this study show that
azelastine significantly inhibits both 45 Ca
uptake and histamine reiease in mast cells
stimulated by antigen. The inhibition of
azelastine on Ca'+ influx into mast cells
might be related to the inhibition on the
production of leukotrienes, and it might be
seggested that azelastin inhibits the release
of leukotrieries and histamine by preventing
an increase in activity of phopholipase A,
stimulated by Ca'+.
References
1. Cox JSG. Disodium cromoglycate (FPL
670) OntaIn) ; a sprcific inhibitor of
reagllllc antibody-antigen mechanisms.
Nature 216: 1328-1336, 1967.
2. Taylor WA, Francis DH, Sheldon D,
Roitt 1M. Antiallergic actions of disodium
cromoglycate and other drugs known to
inhibit 3', 5' -nucleotide phosphodiesterase.
Int Archs Allergy Appl Immunol. 47 : 175-
193, 1974.
3. Ishizaka T, Foreman JC, Sterk AR,
Ishizaka K. Induction of calcium flux
across the rat mast cell membrane by
bridging IgE receptors. Proc Nat! Sci USA
76 : 5858-5862, 1979.
4. Ishizaka T, Hirata F, Ishizaka K, Axelrod
J. Stimulation of phospholipid methyla-
tion, Ca'+ influx and histamine release by
bridging of IgE receptors on rat mast
cells. Proc Nat! Sci USA 77: 1903-1908,
1980.
5. Enis M, Ind PW, Pearce FL, Dollery CT.
Colcium antagonists and histamine release
from rat peritoneal mast cells. Agents
Actions 13: 144-148, 1983.
6. Chand N, Diamantis W, Sofia RD, An-
tagonism of leukotrienes, calcium and
histamine by azelastine. Pharmacologist 26 :
152 -152, 1984.
7. Diamantis W, Chand N, Harison JE,
Pillar J, Perhach JL, Sofia RD, Inhibition
of SRS-A and its antagonism by azelastine
(A),an HI antagonist-antiallergic agent.
Pharmacologist 24: 200-200, 1982.
8. Chand N, Pillar J, Diamantis W, Perhach
JL Jr, Sofia RD. Inhibition of calcium
ionophore (A23187)-stimulated histamine
release from rat peritoneal mast cells by
azelastine. Implications for its mode of
action. Eur J Pharmacol. 96: 227 - 233,
1983.
9. Fields DAS, Pillar J. Diamantis W,
Perhach JL Jr, Sofia RD, Chand N. Inhibi
tion by azelastine of nonallergic histamine
release from rat peritoneal cells. J Allergy
Azelastine and "Ca uptake 93
din Immuno!. 73 : 400-403, 1984.
10. Fisher B, Schmutzler W. Inhibition by
azelastine of the immunologically-induced
histamine release from isolated guinea pig
mast cells. Arzneimittel-Forsch. 31 : 1193-
1195, 1981.
11. Chand N, Pillar J, Diamantis W, Sofia
RD. Inhibition of allergic histamine release
by azelastine and selected antiallergic
drugs from leukocytes. Int Archs Allergy
Appl Immuno!. 77 : 451-455, 1985.
12. Nishihira J, Hayakawa T, Suzuki K, Kato
K, Ishibashi T. Effect of azelastine on
leukotriene synthesis in murine peritoneal
cells and on thromboxane synthesis in
human platelets. Int Archs Allergy Appl
Immuno!. 90 : 285-290, 1989.
13. Foreman JC, Hallet MB, Mongar JL. The
relationship between histamine secretion
and "Ca uptake by mast cells. J. Physio!.
271 : 193-214, 1977.
14. Tanizaki Y, Townley RG. Effect of BSA
on Ca2+ influx in mast cells stimulated by
ovalbumin. Int Archs Allergy Appl Immu-
no!. 70: 143-145, 1983.
15. Ranadive NS, Dahnari N. Movement of
calcium ions and release of histamine from
rat mast cells. Int Archs Allergy Appl
Immuno!. 70 : 143-145, 1980.
16. Tanizaki Y, Komagoe H, Morinaga M,
Kitani H, Goda Y, Kimura 1. Allergen- and
anti-IgE-induced histamine release from
whole blood. Int Archs Allergy Appl
Immuno!. 73 : 141-145, 1984.
17. Tanizaki Y, Komagoe H, Sudo M, Kitani
H, Nakagawa S, Tada S, Takahashi K,
Kimura 1. Basophil histamine release in-
duced by Candida albicans. Relationship to
specific IgE and IgG antibodies. Jpn J
Allergo!. 34 : 422-427, 1985.
18. Sung CP, Saunders HL, Lenhardt E,
Chaknin LW. Further studies on the
tachphylaxis to DSCG. The effect of con-
centration and temperature. Int Archs
Allergy Appl Immuno!. 55 : 385-394, 1977.
19. Tanizaki Y, Akagi K, Lee KN, Townley
RG. Inhibitory effect of nifedipine and
cromolyn sodium on skin reactions and "Ca
uptake and histamine release in rat mast
cells induced by various stimulating agents.
Int Archs Allergy Appl Immuno!. 72 : 102-
109, 1983.
20. Tanizaki Y, Komagoe H, Ohtani H, Tada
S, Takahashi K, Kimura 1. Inhibitory
effect of nicardipine on "Ca uptake and
histamine release in mast cells stimulated
by antigen. Jpn J Allergo!. 134: 204 - 209,
1985.
21. Kusner EJ, Dubnick B, Herzig DJ. The
inhibition by disodium cromoglycate in
vitro of anaphylactically-induced histamine
release from rat peritoneal mast cells. J
Pharmac Exp Ther. 184 : 41-46, 1973.
22. Thomson DS, Evans DP. Inhibition of
immediate hypersesitivity reactions by
sodium cromoglycate. Requirement for
activity in two laboratory models. Clin
Exp Immuno!. 13: 537 - 544, 1973.
23. Tanizaki Y, Komagoe H, Ohtani J,
Maeda M, Kitani H, Takahashi K, Kimura
1. Effect of DSCG on immunolgical secre-
tory process of mast cells. Relationship to
the tachyphylaxis. 7: 202-207, 1983.
24. Evans DP, Marshall PW, Thomson DS.
Inhibition of immediate hypersensitivity
reactions in the rat by ICI 74 717 and
disodium cromoglycate. Tachyphylaxis and
cross reactivity in vivo and in vitro. Int
Archs Allergy Appl Immuno!. 49: 417-427,
1975.
94 Azelastineand45Cauptake
ラット腹腔肥満細胞のCa2'influxおよびヒスタ
ミン遊離に対する抗アレルギー薬アゼラスチンの
抑制効果について
谷崎勝朗,大谷 純1),木村郁郎1)
岡山大学医学部附属病院三朝分院内科,1)医学部
第2内科
抗原刺激時の,ラット腹腔肥満細胞の Ca2+
uptakeおよびヒスタミン遊離に対する,抗アレ
ルギー薬アゼラスチンの抑制効果について検討を
加えた｡その結果,1.アゼラスチンは抗原刺激
時の肥満細胞の Ca2十uptakeに対して濃度依存
性の抑制効果を示した｡2.同様に,抗原刺激時
の肥満細胞からのヒスタミン遊離に対しても,濃
度依存性の抑制効果を示した｡3.アゼラスチン
の再暴露による抑制効果の減弱傾向は見られず,
アゼラスチンではtachyphylaxisは観察されなかっ
た｡
キーワード:アゼラスチン, ラット肥満細胞,
Ca2+uptake, ヒスタミン遊離
